Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HC001 granules for acute watery diarrhea in children
ChiCTR2300078392Phase 2Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of finerenone in acute watery diarrhea (2 arms), sponsored by Peking University Third Hospital. Primary endpoints: Efficacy of diarrhea, Onset time of antidiarrheal effect and 2 more. Started Jul 2022; status: recruiting.
02
Drugs
finerenone
03
Conditions
acute watery diarrhea
Beyond the preview
Go deeper on ChiCTR2300078392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078392.